Screener
AbCellera Biologics Inc. ABCL Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from AbCellera Biologics Inc.’s reported figures.
The source filing: AbCellera Biologics Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:28 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001703057-26-000046
FAQ
- What is AbCellera Biologics Inc.'s enterprise value?
- AbCellera Biologics Inc. (ABCL) reported enterprise value of $2.39B in Q2 2026.
- How has AbCellera Biologics Inc.'s enterprise value changed year-over-year?
- AbCellera Biologics Inc.'s enterprise value increased by 112.6% year-over-year, from $1.12B to $2.39B.
- What is the long-term trend for AbCellera Biologics Inc.'s enterprise value?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s enterprise value has grown at a -37.3% compound annual growth rate (CAGR), from $10.74B to $1.04B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about AbCellera Biologics Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude